<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>CLINICAL AND LABORATORY FEATURES OF NEPHROPATHY DEVELOPMENT IN INDIVIDUALS WITH OVERWEIGHT AND OBESITY</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Mamirova Marxabo</mods:namePart><mods:namePart type="family">Mamirova Marxabo</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Overweight and obesity are considered important risk factors for the development of renal damage. Increased body weight contributes to insulin resistance, arterial hypertension, dyslipidemia, chronic inflammation, and glomerular hyperfiltration. As a result, microalbuminuria, decreased filtration capacity, and signs of nephropathy develop in the kidneys. Therefore, early laboratory assessment of renal function in individuals with overweight and obesity has significant scientific and practical importance.&#13;
&amp;nbsp;</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-05</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>